The development of pharmacogenomic models to predict drug response

被引：0
|
作者：
Adam, GIR [1 ]
Sanders, R [1 ]
Jonsson, J [1 ]
机构：
[1] Eurona Med, S-75106 Uppsala, Sweden
来源：
TRENDS IN BIOTECHNOLOGY | 1999年
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
The medical community as a whole is aware that patients show variable responses to drug treatments but physicians currently lack efficient tools to predict these drug responses and to select appropriate treatments. Coupling our knowledge of genetic polymorphisms with clinical-response data promises a bright future for rapid advances in personalized medicine.
引用
收藏
页码：30 / 33
页数：4
相关论文
共 50 条
  • [21] Mobilizing pharmacogenomic analyses during clinical trials in drug development
    Bienfait, Karina L.
    Shaw, Peter M.
    Murthy, Gowri
    Warner, Amelia Wall
    [J]. PHARMACOGENOMICS, 2013, 14 (10) : 1227 - 1235
  • [22] The impact of FDA guidance on pharmacogenomic data submissions on drug development
    Little, S
    [J]. IDRUGS, 2005, 8 (08) : 648 - 650
  • [23] Pharmacogenomic Approach to Antimyopia Drug Development: Pathways Lead the Way
    Tkatchenko, Tatiana V.
    Tkatchenko, Andrei V.
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2019, 40 (11) : 833 - 852
  • [24] Profiles predict drug response
    Arnaud, C
    [J]. CHEMICAL & ENGINEERING NEWS, 2006, 84 (17) : 12 - 12
  • [25] Pharmacogenomic biomarkers do not predict response to drotrecogin alfa in patients with severe sepsis
    Annane, Djillali
    Mira, Jean-Paul
    Ware, Lorraine B.
    Gordon, Anthony C.
    Hinds, Charles J.
    Christiani, David C.
    Sevransky, Jonathan
    Barnes, Kathleen
    Buchman, Timothy G.
    Heagerty, Patrick J.
    Balshaw, Robert
    Lesnikova, Nadia
    de Nobrega, Karen
    Wellman, Hugh F.
    Neira, Mauricio
    Mancini, Alexandra D. J.
    Walley, Keith R.
    Russell, James A.
    [J]. ANNALS OF INTENSIVE CARE, 2018, 8
  • [26] Projection of drug response through mechanism-based models in drug development
    Kawai, Ryosei Leo
    [J]. DRUG METABOLISM REVIEWS, 2011, 43 : 15 - 15
  • [27] Pharmacogenomic biomarkers do not predict response to drotrecogin alfa in patients with severe sepsis
    Djillali Annane
    Jean-Paul Mira
    Lorraine B. Ware
    Anthony C. Gordon
    Charles J. Hinds
    David C. Christiani
    Jonathan Sevransky
    Kathleen Barnes
    Timothy G. Buchman
    Patrick J. Heagerty
    Robert Balshaw
    Nadia Lesnikova
    Karen de Nobrega
    Hugh F. Wellman
    Mauricio Neira
    Alexandra D. J. Mancini
    Keith R. Walley
    James A. Russell
    [J]. Annals of Intensive Care, 8
  • [28] Pharmacogenomic Determinants of Interindividual Drug Response Variability: From Discovery to Implementation
    Scott, Stuart A.
    Swen, Jesse J.
    [J]. GENES, 2021, 12 (03)
  • [29] UTILIZATION OF PHARMACOGENOMIC INFORMATION IN BIOEQUIVALENCE STUDIES FOR GENERIC DRUG DEVELOPMENT.
    Li, K.
    Boyce, H.
    Lee, S.
    Frost, M.
    Kim, M.
    Shon, J.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 : S30 - S30
  • [30] Pharmacogenomic blood-based assay to predict chemotherapy response and survival in pancreatic cancer
    Yu, Kenneth H.
    McCarthy, Brian
    Isacoff, William H.
    Cooper, Brandon
    Bartlett, Andrew
    Park, Jennifer
    Purcell, Fay
    McCarthy, Devan
    O'Reilly, Eileen Mary
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
12345